Leishmaniasis cutánea y mucocutánea: abordaje clínico, diagnóstico y terapéutico

• Martinez Rico, J.C. ^[1] ; Herz Ruelas, M.E. ^[1] ; Ocampo Candiani, J. ^[1]
  1. [1] Servicio de Dermatología, Hospital Universitario «Dr. José Eleuterio González», Monterrey, Nuevo León, México
• Localización: Piel: Formación continua en dermatología, ISSN 0213-9251, Vol. 36, Nº. 1 (ENERO), 2021, págs. 22-30
• Idioma: español
• DOI: 10.1016/j.piel.2019.12.004
• Títulos paralelos:
  • Cutaneous and mucocutaneous leishmaniasis: Clinical, diagnostic and therapeutic approach
• Enlaces
  • Texto Completo Ejemplar
• Referencias bibliográficas
  • World Health Organization. What is Leishmaniasis? Disponible en:http://www.who.int/leishmaniasis/disease/en/. Consultada el 9 de noviembre...
  • Vargas MF, Torres G, Arenas R, Quintanilla CMR. Leishmaniasis en México. Med Cutan Iber Lat Am. 2011;39:163–183.
  • Dey A, Singh S. Transfusion transmitted leishmaniasis: a case report and review of literature. Indian J Med Microbiol. 2006;24 (3):165–170.
  • Alemayehu B, Alemayehu M. Leishmaniasis: a review on parasite, Vector and Reservoir Host. Health Sci J. 2017;11(4):519, . https://doi.org/10.21767/1791-809X.1000519.
  • World Health Organization. Neglected Tropical Diseases. Disponible en:http://www.who.int/neglected_diseases/ diseases/en/. Consultada el 9...
  • Centers for Disease Control and Prevention. Parasites-Leishmaniasis. Epidemiology & risk factors. Disponible en: https:// www.cdc.gov/parasites/leishmaniasis/epi.html....
  • World Health Organization. Leishmaniasis. Disponible en: http://www.who.int/es/news-room/fact-sheets/detail/ leishmaniasis. Consultada el...
  • Akhoundi M, Kuhls K, Cannet A, et al. A Historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies....
  • Pace D. Leishmaniasis. J Infect. 2014;69(suppl 1):S10–S18.
  • García-Almagro D. Cutaneous leishmaniasis. Actas Dermosifiliogr. 2005;96(1):1–24, . https://doi.org/10.1016/S0001- 7310(05)73027-1.
  • Centers for Disease Control and Prevention. Parasites-Leishmaniasis. Biology. Disponible en: https://www.cdc.gov/ parasites/leishmaniasis/biology.html....
  • Hepburn NC. Cutaneous leishmaniasis. Clin Exp Dermatol. 2000;25(5):363–370, . https://doi.org/10.1046/j.1365-2230.2000. 00664.x.
  • Grevelink SA, Lerner EA. Leishmaniasis. J Am Acad Dermatol. 1996;34(2 Pt 1):257–272.
  • Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. F1000Res. 2017;6:750, . https://doi.org/10.12688/f1000research.11120.1.
  • Handler MZ, Patel PA, Kapila R, Al-Qubati Y, Schwartz RA. Cutaneous and mucocutaneous leishmaniasis: differential diagnosis, diagnosis, histopathology,...
  • Handler MZ, Patel PA, Kapila R, Al-Qubati Y, Schwartz RA. Cutaneous and mucocutaneous leishmaniasis: Clinical perspectives. J Am Acad Dermatol....
  • Hashiguchi Y, Gomez EL, Kato H, Martini LR, Velez LN, Uezato H. Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced...
  • Andrade-Neto VV, Cunha-Junior EF, Dos Santos Faioes V, et al. Leishmaniasis treatment: update of possibilities for drug repurposing. Front...
  • McGwire BS, Satoskar AR. Leishmaniasis: clinical syndromes and treatment. QJM. 2014;107(1):7–14, . https://doi.org/10.1093/ qjmed/hct116.
  • Mohammadpour I, Motazedian MH, Handjani F, Hatam GR. Lip leishmaniasis: a case series with molecular identification and literature review....
  • David CV, Craft N. Cutaneous and mucocutaneous leishmaniasis. Dermatol Ther. 2009;22(6):491–502, . https://doi.org/10. 1111/j.1529-8019.2009.01272.x.
  • Crovetto-Martinez R, Aguirre-Urizar JM, Orte-Aldea C, Araluce-Iturbe I, Whyte-Orozco J, Crovetto-de la Torre MA. Mucocutaneous leishmaniasis...
  • Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392 (10151):951–970, . https://doi.org/10.1016/S0140-6736(18)31204-2.
  • Ameen M. Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics. Clin Exp Dermatol. 2010;35(7):699–705, ....
  • Elmahallawy EK, Sampedro Martinez A, Rodriguez-Granger J, et al. Diagnosis of leishmaniasis. J Infect Dev Ctries. 2014;8(8): 961–972, . https://doi.org/10.3855/jidc.4310.
  • Meireles CB, Maia LC, Soares GC, et al. Atypical presentations of cutaneous leishmaniasis: a systematic review. Acta Trop. 2017;172:240–254,...
  • Palumbo E. Treatment strategies for mucocutaneous leishmaniasis. J Glob Infect Dis. 2010;2(2):147–150, . https://doi.org/ 10.4103/0974-777X.62879.
  • Aronson N, Herwaldt BL, Libman M, et al. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases...
  • Khalifa ES, Adil AN, Ahmed G, Al-Ghazzi. Treatment of cutaneous leishmaniasis by topical 25% podophyllin solution (single, blinded, therapeutic,...
  • Salmanpour R, Razmavar MR, Abtahi N. Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment...
  • De Vries HJ, Reedijk SH, Schallig HD. Cutaneous leishmaniasis: recent developments in diagnosis and management. Am J Clin Dermatol. 2015;16(2):99–109,...
  • Goto H, Lindoso JA. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther. 2010;8(4):419–433,...
  • Monge-Maillo B, Lopez-Velez R. Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidencebased treatment recommendations....
  • Vakil NH, Fujinami N, Shah PJ. Pharmacotherapy for leishmaniasis in the United States: focus on miltefosine. Pharmacotherapy. 2015;35(5):536–545,...
  • Ghorbani M, Farhoudi R. Leishmaniasis in humans: drug or vaccine therapy? Drug Des Devel Ther. 2018;12:25–40, . https:// doi.org/10.2147/DDDT.S146521.